SK

Sri Kanth Kasala

Active Director Whole-Time Director DIN 06530290
DIN 06530290 First appointment Jan 2018 Primary industry Business Outsourcing
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2018
Shareholding value •••• Premium profile

About Sri Kanth Kasala

Data last updated:

Sri Kanth Kasala is a Whole-Time Director at Eliscription Private Limited (since 2018) and Whole-Time Director at Elicognis Private Limited (since 2018). The companies operate in Business Outsourcing. The 2 current companies with reported revenue have a combined latest revenue of ₹15.79 Cr; the largest is Eliscription Private Limited at ₹7.90 Cr (FY 2025).

DIN 06530290
Primary Designation Whole-Time Director
Industry Business Outsourcing
First Appointment 01 Jan 2018
Oldest Company Age 13 yrs
Largest company Eliscription Private Limited · ₹7.90 Cr (FY 2025)
Combined revenue ₹15.79 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Eliscription Private Limited U74900TG2013PTC086622
Whole-Time Director01 Jan 20182013₹7.90 Cr (FY 2025)Active
Elicognis Private Limited U63119TG2013PTC086622
Whole-Time Director01 Jan 20182013₹7.90 Cr (FY 2025)Active

Board colleagues of Sri Kanth Kasala

Directorship timeline

Open interactive timeline →
Eliscription Private Limited
Elicognis Private Limited
Premium access

Shareholding and investment profile for Sri Kanth Kasala

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sri Kanth Kasala

Sri Kanth Kasala currently holds 2 directorships: Eliscription Private Limited (Whole-Time Director, since 01 Jan 2018, revenue ₹7.90 Cr (FY 2025)); Elicognis Private Limited (Whole-Time Director, since 01 Jan 2018, revenue ₹7.90 Cr (FY 2025)).

Sri Kanth Kasala was first appointed on 01 Jan 2018 as Whole-Time Director at Eliscription Private Limited.

The 2 current companies of Sri Kanth Kasala that report revenue have a combined latest revenue of ₹15.79 Cr: Eliscription Private Limited ₹7.90 Cr (FY 2025); Elicognis Private Limited ₹7.90 Cr (FY 2025).

The current boards of Sri Kanth Kasala's companies include Ramesh Datla (Eliscription Private Limited), Vanitha Datla (Eliscription Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available